Open AccessP1710: LISOCABTAGENE MARALEUCEL (LISO‐CEL) AS SECOND‐LINE TREATMENT FOR R/R LARGE B‐CELL LYMPHOMA (LBCL) IN PATIENTS NOT INTENDED FOR HSCT: PATIENT‐REPORTED OUTCOMES (PRO) FROM THE PHASE 2 PILOT STUDY
Author(s) -
Gordon L. I.,
Hoda D.,
Shi L.,
Guo S.,
Liu F. F.,
Braverman J.,
Dubowy R.,
Peng L.,
Sehgal A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849696.81993.90
Subject(s) - medicine , hematopoietic stem cell transplantation , quality of life (healthcare) , oncology , transplantation , nursing